8:45 CAFÉ DE BIENVENUE

​

9:30  : Discours d'ouverture par Isabelle DIMIER-POISSON

​

 

 Part I : Overview of viruses

​

9:45-11:10  : Daniel MARC (INRA - Avian immune response and pathogenesis - TOURS)

        Viruses: tireless, undisciplined explorers of life.

​​

10:15-10:45  : Olivier REYNARD (CIRI – Molecular bases of viral pathology – LYON)

          Ebola virus infection: toward a better understanding of the initial steps. 

​

PAUSE (10:45-11:05)

​

11:10-11:40 : Jade COCHARD  (INSERM – MAVIVH – TOURS)

           Cell culture production of HCV particles highly infectious and morphologically similar to naïve HCV particles.

​

11:45-12:15 : Karl STEFIC (INSERM – MAVIVH – TOURS)

          Monitoring the sensitivity to broadly neutralizing antibodies of HIV-1 strains transmitted in France

 

PAUSE REPAS (12:15-13:45)

​

Part II : Virus comme solutions thérapeutiques

 

13:45–14:15 : Jérémy BEGUIN (National Veterinary School of Alfort – TRANSGENE – PARIS)

          New therapeutic strategy using a double deleted oncolytic Vaccinia virus encoding FCU1 protein (TG6002) against canine cancers.

​​

14:20–14:50 : Karim BENIHOUD (Institute Gustave ROUSSY – Viral Vectorology – PARIS)

         Vaccination by epitope display on adenovirus capsid.

​

PAUSE (14:55-15:15)

​

15:15–15:45 : Catherine SCHOULER (INRA – Pathogenesis of avian colibacillosis – TOURS)

          Biocontrol of avian colibacillosis by phages.

​

15:50-16:20 : Martine CERUTTI (Labex MabImprove – Baculovirus and therapy – MONTPELLIER)

          A new baculovirus expression system for the production of highly glycosylated multi-subunit proteins : application to the production of antibody, antibody-derived molecules and vaccines.

​​

16:25 DISCOURS DE CLÔTURE

​

Cérémonie de Fin